ModernVivo
Private Company
Funding information not available
Overview
ModernVivo is a private, early-stage biotech software company founded in 2018 and based in Cambridge, Massachusetts. It has developed an AI-driven platform that automates the extraction of insights from scientific literature to streamline and optimize the design of in vivo preclinical studies. By reducing the time and cost associated with manual literature reviews, the company aims to improve research efficiency, enhance study quality, and support ethical animal use. Its business model is a SaaS-based platform, positioning it as a tool provider rather than a therapeutic developer.
Technology Platform
AI-powered software for automated extraction and synthesis of experimental parameters from scientific literature to optimize in vivo study design.
Opportunities
Risk Factors
Competitive Landscape
Competitors include large scientific information providers like Elsevier (Scopus, Reaxys) and Digital Science, which are integrating AI tools. Also faces competition from AI-focused literature analysis startups such as BenchSci, Semantic Scholar, and Iris.ai. Differentiation hinges on deep specialization in in vivo study parameters and workflow integration.